News

Recent Letters from the Director

The Online GLP-1 Marketplace

July 31, 2026

A recent research letter published in JAMA by Chetty et al describes the experience of a secret shopper in obtaining GLP-1 receptor agonists (GLP-1 RA) from online sources.

Understanding PMOS

June 30, 2026

PCOS was recently renamed polyendocrine metabolic ovarian syndrome (PMOS) to address the inadequate treatment that has resulted from its perception as a condition limited to fertility.

Lessons from the STOP Obesity Alliance: A Reflection on Obesity Advocacy

May 29, 2026

This month's author is, Aden Belay, MPH, the STOP Obesity Alliance student research assistant who recently graduated from the Milken Institute School of Public Health.

News Archive

The Impact of Rising Rates of Obesity and Diabetes

December 1, 2024

November was National Diabetes Month, which provides a perfect opportunity to remind us to look again at the associated diagnoses of diabetes for individuals with obesity.

Compounding of GLP-1 Drugs

October 31, 2024

Due to the shortages of obesity medications, some patients are turning to pharmacies that produce compounded versions of these medications.

New ICD-10 Codes for the Diagnosis of Obesity

October 8, 2024

In September 2023, the National Center for Health Statistics (NCHS) approved updated ICD-10-CM obesity codes and they go into effect on October 1, 2024.

Guest Letter: Cardio-Kidney-Metabolic Syndrome

September 2, 2024

What you need to know about Cardio-Kidney-Metabolic Syndrome.

What are 'Ozempic Babies' and How Does Obesity Impact Women?

August 1, 2024

Hormonal differences, like Polycystic Ovary Syndrome (PCOS), and the implications of obesity for fertility illustrate some of the ways in which women’s experiences with obesity diverge from those of men.